Hearing After Induction Chemotherapy and Definitive Chemoradiotherapy in Advanced Oropharyngeal Carcinoma

doi 10.1055/s-0038-1640119
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Neoadjuvant vs Definitive Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Patients

World Journal of Surgical Oncology
SurgeryOncology
2018English

Adjuvant Chemotherapy (Nedaplatin/Uft) After Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Journal of Otolaryngology of Japan
Otorhinolaryngology
2006English

Prediction of Concurrent Chemoradiotherapy Outcome in Advanced Oropharyngeal Cancer

International Journal of Oncology
Cancer ResearchOncology
2014English

Lymph Node Enlargement After Definitive Chemoradiotherapy for Clinical Stage I Esophageal Squamous Cell Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Randomized Trial of Neoadjuvant Chemotherapy in Oropharyngeal Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2000English

Salvage Hyperthermo-Chemotherapy for Local Recurrence of Cervical Esophageal Cancer After Definitive Chemoradiotherapy: A Case Report

Thermal Medicine
2009English

Genetic Variations in Radiation and Chemotherapy Drug Action Pathways and Survival in Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Chemoradiotherapy

PLoS ONE
Multidisciplinary
2013English

Comparing Outcomes of Concurrent Chemotherapy Regimens in Patients 65 Years or Older With Locally Advanced Oropharyngeal Carcinoma

Cancer
Cancer ResearchOncology
2018English

Reduction of Target Volume and the Corresponding Dose for the Tumor Regression Field After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Cancer Research and Treatment
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy